| # | Drug | Count |
|---|---|---|
| 0 | PANTOPRAZOLE | 89 |
| 1 | PREDNISOLONE | 78 |
| 2 | PREDNISOLONE ORAL | 78 |
| 3 | PREDNISOLONE ORAL SOLUTION | 78 |
| 4 | DABIGATRAN ETEXILATE | 72 |
| 5 | DABIGATRAN ETEXILATE MESYLATE | 69 |
| 6 | BEVACIZUMAB | 64 |
| 7 | FLUOROURACIL | 56 |
| 8 | FLUOROURACIL CREAM, 0.5% | 56 |
| 9 | ASPIRIN | 53 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAPHTHALENE | 1 | 0.2500 |
| 1 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 1 | 0.0714 |
| 2 | CARBON DIOXIDE | 1 | 0.0087 |
| 3 | COUMARIN | 1 | 0.0061 |
| 4 | BEVACIZUMAB-ADCD | 1 | 0.0049 |
| 5 | CHORIOGONADOTROPIN ALFA | 10 | 0.0038 |
| 6 | CLORAZEPATE DIPOTASSIUM | 7 | 0.0036 |
| 7 | CLEMASTINE FUMARATE | 4 | 0.0029 |
| 8 | SALICYLIC ACID 12% | 5 | 0.0026 |
| 9 | ASTRINGENT | 5 | 0.0026 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 203 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 123 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 91 |
| 3 | Platinum-based Drug [EPC] | 85 |
| 4 | Proton Pump Inhibitor [EPC] | 75 |
| 5 | Atypical Antipsychotic [EPC] | 67 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 66 |
| 7 | Loop Diuretic [EPC] | 61 |
| 8 | Benzodiazepine [EPC] | 55 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 53 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Gonadotropin [EPC] | 10 | 0.0046 |
| 1 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 2 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 3 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 4 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 11 | 0.0009 |
| 6 | Leptin Analog [EPC] | 1 | 0.0008 |
| 7 | Lipid Emulsion [EPC] | 2 | 0.0008 |
| 8 | Vitamin D2 Analog [EPC] | 4 | 0.0006 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |